tirzepatide coming off People Who Stopped Taking the Weight Loss Drug Regained Nearly Half the Weight They Lost Two Years After Stopping GLP-1s,

41 Overall, oral semaglutide, the single oral GLP1-RA agent, seems to be an effective and safe hypoglycemic agent in T2DM and might be considered as a promising future alternative option and an add-on therapy to further improve Hb1Ac and reduce weight, while securing a low risk of hypoglycaemic episodes

It is important to note that these mechanistic effects are still being characterised in human studies, and the relative contribution of each receptor pathway to the drug's overall effects remains under investigation

Dual-Compound Protocol: When Single-Agent Response Plateaus Some patients experience incomplete appetite suppression recovery even with aggressive dose escalation of tirzepatide alone

After 5 years, this amount decreases progressively until it is halved

Which has fewer side effects, Amycretin or CagriSema

Theranostics 12 , 44774497 (2022)